FDA Class IFDA·Medicines·March 11, 2026

Mohamed Hagar recalls Mojo Max Fusion XXX capsules over undeclared sildenafil and tadalafil

FDA testing found that Mojo Max Fusion XXX capsules contain sildenafil (13.1 mg per capsule) and tadalafil (13.8 mg per capsule), which are not declared, and the product is marketed without an approved NDA/ANDA.

What to do

The notice does not give instructions. Read the official notice for details.

Note from Recalled Today: Don't stop taking a prescribed medicine before you talk to your pharmacist or doctor.

Recall details

Product
Mojo Max Fusion XXX, 500 mg, one capsule per blister card, 20 count box, Distributed by: Max Nutrition Inc. UPC 6 78945 36675 0
Hazard
Marketed Without an Approved NDA/ANDA-FDA analysis revealed undeclared sildenafil (13.1 mg/capsule) and tadalafil (13.8 mg/capsule).
Units
125 boxes
Where sold
U.S. Nationwide
FDA classification
Class I · Ongoing
Classified by FDA
March 17, 2026
Recall started
October 8, 2025
FDA enforcement report
March 11, 2026
Identifiers
  • Codes: ALL LOTS, exp 12/31/2027
  • FDA recall number: D-0396-2026

The headline, summary and steps above are written in plain English from the official notice below. Identifiers are copied exactly as the agency published them. Always check the official notice before you act.

Official notice

The notice's own wording from FDA.

Product
Mojo Max Fusion XXX, 500 mg, one capsule per blister card, 20 count box, Distributed by: Max Nutrition Inc. UPC 6 78945 36675 0
Reason for recall
Marketed Without an Approved NDA/ANDA-FDA analysis revealed undeclared sildenafil (13.1 mg/capsule) and tadalafil (13.8 mg/capsule).
Classification
Class I (Ongoing)
Distribution
U.S. Nationwide
Quantity
125 boxes

Related recalls